texas oncology more breakthroughs. more victories
  • Request an Appointment
  • Find a cancer center
  • Find a provider
  • Clinical Trials

Share:

 
 

Hareesha Vemuganti, M.D.

General Summary

Education

  • Fellowship in Medical Oncology and Hematology
    Drexel University College of Medicine, Hahnemann University Hospital, Philadelphia, PA
  • Residency in Internal Medicine, Chief Resident
    Crozer-Keystone Health System, Upland, PA
  • Internship
    Michigan State University / Hurley Medical Center, Flint, MI
  • Medical Doctorate
    Bharati Vidyapeeth Medical College, Pune, India

Medical Practice

Research Interest

Surgery Locations

Other Information

Dr. Vemuganti was born and raised in India, and is fluent in English, Telugu, and Hindi. After relocating to the Philadelphia area to complete her residency and fellowship, she is happy to finally call Texas home. She enjoys traveling and spending quality time with her husband and two children.

Accolades & Memberships

  • American Society of Clinical Oncology
  • American Society of Hematology
  • American Medical Association

Community Service

Philosophy of Care

Dr. Vemuganti strives to achieve the highest quality of patient care through practicing evidence-based medicine. She believes in treating each patient as a whole person, respecting their individual beliefs, and tailoring their treatment accordingly. An effective treatment plan begins with open communication. Dr. Vemuganti ensures that her patients are well informed and she makes addressing their needs and concerns her top priority.

Publications

  • Comparison of Survival Outcomes and Demographic Trends of Uterine Sarcomas Between a Single Institution and the National Surveillance Epidemiology & End Result Database (SEER) from 2002-2012

    Journal of Clinical Oncology, 2016

  • Upper Alveolar Ridge Metastases from Colon Cancer: A Unique Presentation of Metastatic Colon Cancer

    American College of Gastroenterology, 2016

  • A Retrospective Analysis of Myeloproliferative Neoplasms: Treatment Approach and Outcomes at Drexel University Hospital

    American Society of Hematology, 2015

  • Cholangiocarcinoma: Treatment with Sorafenib Extended Life Expectancy to Greater than Four Years

    Journal of Gastrointestinal Oncology, 2013